These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 4597622)

  • 41. Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction.
    Vánky R; Klein E; Stjernswärd J; Nilsonne U
    Int J Cancer; 1974 Aug; 14(2):277-88. PubMed ID: 4376515
    [No Abstract]   [Full Text] [Related]  

  • 42. Transplantation tolerance and enhancement. Concepts and questions.
    Elkins WL; Hellström I; Hellström KE
    Transplantation; 1974 Jul; 18(1):38-45. PubMed ID: 4151912
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibition of spontaneous allorosette formation by sera from tolerant rats.
    Gluckman JC; Bansal SC; Wright PW; Hellström KE
    Transplantation; 1974 Jan; 17(1):97-110. PubMed ID: 4588159
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro immunization to cultured human tumor cells.
    Sharma B; Terasaki PI
    Cancer Res; 1974 Jan; 34(1):115-8. PubMed ID: 4129196
    [No Abstract]   [Full Text] [Related]  

  • 45. Cytophilic antibody as an auxiliary factor in cell-mediated immunity.
    Ptak W
    Allerg Immunol (Leipz); 1973; 19(2-4):290-6. PubMed ID: 4375939
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 47. Lymphocyte-mediated cytolysis of allogeneic tumor cells in vitro. I. Search for target antigens in subcellular fractions.
    Todd RF; Stulting RD; Amos DB
    Cell Immunol; 1975 Aug; 18(2):304-23. PubMed ID: 806359
    [No Abstract]   [Full Text] [Related]  

  • 48. Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse.
    Nabholz M; Vives J; Young HM; Meo T; Miggiano V; Rijnbeek A; Shreffler DC
    Eur J Immunol; 1974 May; 4(5):378-87. PubMed ID: 4277395
    [No Abstract]   [Full Text] [Related]  

  • 49. Cytotoxic activity of lymphocytes. 3. Standardization of measurement of cell-mediated lysis.
    Lucas ZJ; Walker SM
    J Immunol; 1974 Jul; 113(1):209-24. PubMed ID: 4598888
    [No Abstract]   [Full Text] [Related]  

  • 50. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 51. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 52. Mechanisms of immunosuppression by antilymphocyte antibody.
    Taub RN
    Pathobiol Annu; 1972; 2():129-51. PubMed ID: 4149315
    [No Abstract]   [Full Text] [Related]  

  • 53. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 54. Abrogation of cell-mediated immunity by hyperimmune alloantiserum: mechanisms and correlation with allograft enhancement.
    Cohen JM; Yang SS; Law LW
    Int J Cancer; 1974 Apr; 13(4):463-77. PubMed ID: 4135340
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The H-2 complex: immunogenicity and enhancement studies of H-2K region alloantigens.
    McKenzie IF; Henning MM
    J Immunogenet; 1977 Aug; 4(4):249-57. PubMed ID: 334998
    [No Abstract]   [Full Text] [Related]  

  • 57. Cell-mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo.
    Nicolin A; Bini A; Franco P; Goldin A
    Cancer Chemother Rep; 1974; 58(3):325-30. PubMed ID: 4841716
    [No Abstract]   [Full Text] [Related]  

  • 58. Developmental aspects of delayed hypersensitivity.
    Berkel AI
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:147-51. PubMed ID: 4277433
    [No Abstract]   [Full Text] [Related]  

  • 59. Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation.
    Garovoy MR; Franco V; Zschaeck D; Carpenter CB; Strom TB; Merrill JP
    Lancet; 1973 Mar; 1(7803):573-6. PubMed ID: 4120643
    [No Abstract]   [Full Text] [Related]  

  • 60. Activation of specific cellular immunity toward murine leukemia in mice rejecting syngeneic somatic hybrid cells.
    Liang W; Cohen EP
    J Immunol; 1977 Sep; 119(3):1054-60. PubMed ID: 302270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.